286
Participants
Start Date
November 30, 2006
Primary Completion Date
December 31, 2009
Study Completion Date
August 31, 2011
Zalutumumab
Individual dose titration weekly i.v doses
Control
Best Supportive Care
University Hospital Antwerp, Antwerp
St-Luc University Hospital, Brussels
CHNDRF, Charleroi
"University Hospital", Ghent
University Hospital Leuven, Leuven
Cliniques Saint Pierre, Ottignies
BioCancer, Belo Horizonte
Hospital Erasto Gaertner, Curitiba
Centro Goiano de Oncologia, Goiânia
Hospital Araújo Jorge, Goiânia
Fundação Amaral Carvalho, Jaú
CliniOnco, Porto Alegre
Hospital de Clínicas de Porto Alegre, Porto Alegre
Cepho - Centro de Estudos e pesquisa em Hematologia e Oncologia, Santo André
Santo Andre Diag e Tratamentos, Santo André
Centro de Oncologia - InRad HCFMUSP, São Paulo
Hospital Heliópolis, São Paulo
IBCC - Instituto Brasileiro de Combate ao Câncer, São Paulo
UNIFESP, São Paulo - SP
Tom Baker Cancer Centre, Calgary
Cross Cancer Institute, Edmonton
London Regional Cancer Program, London
Princess Margaret Hospital, Toronto
BC Cancer Agency, Vancouver, British Colombia
North-Estonian Regional Hospital, Tallinn
Hôpital Beaujon- department of medical oncology, Clichy
Centre Oscar Lambrette, Lille
Centre Antoine Lacassagne, Nice
Hôpital Tenon - department of medical oncology, Paris
Institut Gustave Roussy, Villejuif
Semmelweis University, Budapest
Uzsoki Hospital Budapest, Budapest
University of Debrecen, Debrecen
Petz Aladár, Győr
Szabolcs-Szatmar-Bereg County Hospital, Nyíregyháza
University of Szeged, Szeged
Markusovszky County Hospital, Szombathely
Szent Borbála County Hospital Oncology Department, Tatabánya
Zala County Hospital, Zalaegerszeg-Pózca
Klaipeda Hospital, Klaipėda
Vilnius University, Vilnius
Beskidzkie Centrum Onkologii, Bielsko-Biala
Samodzielny Publiczny Szpital Kiniczny Nr1, Gdansk
Katedra i Onkologii Collegium, Krakow
Szpital Specjalistyczny im. Rydygiera, Krakow
Centrum Onkologii, Lublin
Zakład Opieki Zdrowotnej MSWiA z Warmińsko-Mazurskim Centrum Onkologii w Olsztynie, Olsztyn
Centrum Onkologii - Instytut im. M. Curie-Skłodowskiej, Warsaw
Dolnoslaskie Centrum Onkologii, Wroclaw
Szpital Wojewódzki SP ZOZ, Zielona Góra
Belgorod Regional Oncology Dispensary, Belgorod
Regional Oncology Dispensary, Chelyabinsk
Republican Clinical Oncology Dispensary, Izhevsk
Kursk Regional Oncology Dispencary, Kursk
Kursk Regional Oncology Dispensary, Kursk
City Clinincal Oncology Dispensary #1, Moscow
Moscow Research Institute of Oncology, Moscow
NUZ Semashko Central Clinical Hospital No2 OAO, Moscow
Russian Oncology Research Center n.a. Blokhin, Moscow
GUZ NO Oncology Dispensary, Nizhiy Novgorod
Medical Radiological Research Center, Obninsk
St. Petersburg State Medical University, Saint Petersburg
Sochi Oncology Center, Sochi
Stavropol Regional Clinical Oncology Dispensary, Stavropol
Tula Region Oncology Dispensary, Tula
GUZ Volgograd Region Clinical Oncology Dispensary No1, Volgograd
Voronezh Region Clinical Oncology Dispensary, Voronezh
Institute for Oncology and Radiology, Belgrade
Military Medical Academy, Belgrade
Institute of Oncology Sremska Kamenica, Kamenica
Clinic of Maxillofacial Surgery Nis, Niš
Sahlgrenska University Hospital, Gothenburg
Lund University Hospital, Lund
Musgrove Park Hospital, Taunton
Royal Surrey County, Guildford
Bristol Haematology and Oncology Centre, Bristol
The Beatson West of Scotland Centre, Glasgow
Royal Marsden Hospital, London
Christie Hospital, Manchester
Newcastle General Hospital, Newcastle
Weston Park Hospital, Sheffield
New Cross Hospital, Wolverhampton
Lead Sponsor
Genmab
INDUSTRY